Autus Size-Adjustable Valve
Edwards Lifesciences, LLC · Decision date Oct 1, 2026
What did the FDA approve?
FDA records P260007 as an original PMA application. The recorded decision is approval, dated Oct 1, 2026.
FDA approval order statement
Approval for AUTUS Size-Adjustable Valve: The AUTUS valve is indicated for the management of pediatric patients weighing greater than or equal to 10 kg who require surgical pulmonary valve replacement for dysfunctional native or surgically-repaired right ventricular outflow tract (RVOT), as determined by echocardiography to meet the following criteria: (1) severe pulmonary stenosis (i.e., right ventricle (RV) to pulmonary artery (PA) peak instantaneous gradient greater than or equal to 60 mmHg); (2) greater than or equal to moderate pulmonary regurgitation; or (3) greater than or equal to moderate pulmonary stenosis (i.e., RV to PA peak instantaneous gradient greater than or equal to 40 mmHg) and greater than or equal to moderate pulmonary regurgitation.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 1, 2026
Regulatory record facts
- Identifier
- P260007
- Regulatory pathway
- Premarket approval application
- Applicant
- Edwards Lifesciences, LLC
- Product code
- SJL
- Decision code
- APPR
- Decision date
- Oct 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Heart-valve, polymeric.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- SJL
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P260007 received
Application receipt date recorded by FDA.
P260007 · FDA decision
APPR
Timeline entries are records held by MedtechLedger for P260007. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P260007
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records